Rainforest Rx
The World’s Original Pharmacy? The Rainforest
Keep Shopping
Did you know?
25% of all medical breakthroughs come from the world’s rainforest.
4 min read
25% of all medical breakthroughs come from the world’s rainforest.
Scientists have studied less than 5% of the 80,000 medicinal plant species for therapeutic purposes.
  • 70% of plants with antioxidant properties come from the world’s rainforests
  • Research guided by indigenous knowledge succeeds 50% of the time vs. 1% for random screening
  • We lose one potential major medical breakthrough every two years to rainforest deforestation
Phytonutrient-Rich
Whole Foods (peel, seeds, stem)
Sustainably Harvested
Did you know?
25% of all medical breakthroughs come from the world’s rainforest.
The rosy periwinkle has transformed childhood leukemia care.
Where Modern Medicine Began
The rainforest is a molecular archive.

Aspirin came from the bark of a rainforest tree.

Quinine, the original malaria drug, derives from the cinchona tree.

Chemotherapy agents like vincristine and vinblastine were first discovered in rainforest periwinkle.

Many of our most powerful treatments come from wild plants in the rainforest, and we’ve only just begun to understand what’s there.
The rosy periwinkle has transformed childhood leukemia care.
The Unique Advantage Of The Rainforest
When grown in the wild, plants produce 25-50x more protective compounds and nutrients to adapt to natural stressors than their farmed counterparts.

Yet when grown in the harsh environments and competitive ecosystems of the rainforest, plants spur even higher nutrient density, more complex nutrient profiles—including rare, stress induced phytonutrients, and deeper concentrations of bioactive compounds than traditional wild varieties.

In humans, these compounds work synergistically to help protect our cells from damage, regulate inflammation, keep our systems resilient and even balance excess calcium in our diets from enriched foods and supplements.
Rainforest Plants
50% success rate in therapeutic identification with indigenous guidance
Available now
Extinction threat, seasonal availability, and sustainability concerns
Multiple compounds work synergistically
Laboratory Synthesis
Less than 5% success rate in therapeutic identification with random screening, improving with AI
10-20 year development cycle
Can’t replicate natural complexity and comes with expensive development
May see side effects from single targets
Still the Future of Health, Unless…
From gut health to immune resilience and next-gen therapeutics, the rainforest remains one of the most promising frontiers in both modern and preventative medicine.

And we’ve only scratched the surface. As low as just 1% of rainforest plants have been studied for medicinal use. The other 99%? At risk of losing its secrets to deforestation and unethical harvesting practices.

When we talk about the future of health, we’re really talking about the future health of our rainforests and why we only engage ethical harvesting practices in partnership with indigenous foragers and land carers.
Phytonutrient Density
Preservation Method
Bioavailability
Whole Matrix
Source
Extremely High
Lyophilized
High
Rainforest
Leading Greens Powder
Low
Spray-Dried
Moderate
Farm
Rainforest Nutrition Without the Wait
While companies spend 10-15 years isolating single compounds from rainforest plants, Buoy delivers access to its complete nutritional benefits today. Our wild rainforest foods contain the same types of protective compounds that inspire breakthrough treatments, preserved in their natural, whole-food form.
  • 23 rainforest plants with documented therapeutic compounds

  • 5,000+ phytonutrients including rare, stress-induced polyphenols, terpenes, and phenolic acids

  • 10x higher antioxidants than cultivated plants (our black currants grow under an ozone hole)

  • 97% nutrients preserved through freeze-drying at peak potency

  • Direct from Australian rainforests where 60,000 years of indigenous use proves efficacy
1. Stanford University, "Breakthrough in production of cancer-treating drug," 2022; Clinical Trials Arena, "FDA orphan drug designation," 2023 ↩
2. Journal of Ethnopharmacology, "Ethnomedicinal knowledge of rainforest ecosystems," 2019; WHO Traditional Medicine Report ↩
3. The Institute of Cancer Research & QBiotics, "Phase I trial results," 2023 ↩
4. Nature Reviews Drug Discovery, "AI for natural product discovery," 2023; Economic Botany, "Value of undiscovered pharmaceuticals" ↩